Neural Tube Defects: From a Proteomic Standpoint
AbstractNeural tube defects (NTDs) are congenital birth defects classified according to their resulting morphological characteristics in newborn patients. Current diagnosis of NTDs relies largely on the structural evaluation of fetuses using ultrasound imaging, with biochemical characterization used as secondary screening tools. The multigene etiology of NTDs has been aided by genetic studies, which have discovered panels of genes mutated in these diseases that encode receptors and cytoplasmic signaling molecules with poorly defined functions. Animal models ranging from flies to mice have been used to determine the function of these genes and identify their associated molecular cascades. More emphasis is now being placed on the identification of biochemical markers from clinical samples and model systems based on mass spectrometry, which open novel avenues in the understanding of NTDs at protein, metabolic and molecular levels. This article reviews how the use of proteomics can push forward the identification of novel biomarkers and molecular networks implicated in NTDs, an indispensable step in the improvement of patient management. View Full-Text
Share & Cite This Article
Puvirajesinghe, T.M.; Borg, J.-P. Neural Tube Defects: From a Proteomic Standpoint. Metabolites 2015, 5, 164-183.
Puvirajesinghe TM, Borg J-P. Neural Tube Defects: From a Proteomic Standpoint. Metabolites. 2015; 5(1):164-183.Chicago/Turabian Style
Puvirajesinghe, Tania M.; Borg, Jean-Paul. 2015. "Neural Tube Defects: From a Proteomic Standpoint." Metabolites 5, no. 1: 164-183.